Florbetapir (18F) PET imaging agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Florbetapir (18F) PET imaging agent, covering 2013-09-19 to 2013-09-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) [Phase 2, Phase 3]